Keyword: R&D

News

Teva Confirms Massive Cost Cuts, Job Losses

15.12.2017 - As had been widely expected, Israel-headquartered Teva Pharmaceuticals – world’s largest generics producer – announced on Dec. 14 it would slash 14,000 jobs, about a quarter of its...

News

Bayer Combines Pharma R&D in one Unit

13.12.2017 - From Jan. 1, 2018, Bayer will streamline its strategic pharmaceutical research and development activities and combine them under a single unit covering the therapeutic areas...

News

UK Life Science Boom despite Brexit?

05.12.2017 - As a UK Parliament-select committee prepared for a public evidence session on Dec. 5, examining scenarios for trading arrangements with the UK post-Brexit, reports were circulating...

News

Teva Realigns, may Slash 25% of Workforce

04.12.2017 - Kåre Schultz, new chief executive officer of debt-plagued Israeli drugmaker Teva, is moving rapidly to make good on his pledge to improve the company’s financial performance and...

News

FDA Approves new Two-drug HIV Treatment

29.11.2017 - The US Food and Drug Administration (FDA) has approved a new two-drug regimen for HIV that reports suggest could shake up the $22 billion market for products to treat the immune...

News

Sasol Refocuses, Exits Shale and GTL

28.11.2017 - Following an evaluation of its portfolio, South African energy and chemical company Sasol has decided to focus on high-value specialty chemicals and withdraw from shale gas and gas...

News

Kemira Invests in Oil Recovery Polymers

28.11.2017 - Finland’s Kemira will spend roughly €30 million to expand its capacity of polymers for Chemical Enhanced Oil Recovery (CEOR) at its site in Botlek, the Netherlands. The additional...

Markets & Companies

Venezuela: Plenty of Room for Improvement

25.11.2017 - Venezuela is one of the emerging pharmaceutical markets in South America, with a major dependence on imports. However, economic and political turmoil along with inefficient patent...